InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.51%
)
US TECH 100
17,660.00
(
0.33%
)
Dow Jones
39,387.76
(
0.85%
)
Brent Oil
84.09
(
0.16%
)
Bitcoin
62,938.73
(
-0.17%
)
Post# of 251777
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119605
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dangerM post# 221556

Monday, 10/22/2018 4:00:30 PM

Monday, October 22, 2018 4:00:30 PM

Post# of 251777

NKTR—...the awareness that anyone can work on a biased IL2 agonist...

It doesn't help that Howard Robin has set expectations so high by referring to NKTR-214 as the "cornerstone of modern immuno-oncology."

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up